Safety and effectiveness of RBD-specific polyclonal equine F(ab´)2 fragments for the treatment of hospitalized patients with severe Covid-19 disease: A retrospective cohort study.
Diego H Farizano SalazarFernando AchinelliMariana ColonnaLucía PérezAnalía A GiménezMaria Alejandra OjedaSusana N Miranda PuenteLía Sánchez NegretteFlorencia CañeteOrnela I Martelotte IbarraSantiago SanguinetiLinus SpatzFernando A GoldbaumCarolina MassaMarta RivasMariana PichelYanina HiriartVanesa ZylbermanSandra GallegoBrenda KonigheimFrancisco FernándezMatías DepratiIan RoubicekDiego H GiuntaEsteban C NanniniGustavo LopardoWaldo H Bellosonull nullPublished in: PloS one (2022)
In this retrospective cohort study, EPIC showed adequate safety and effectiveness in the treatment of hospitalized patients with severe SARS-CoV-2 disease.